Skip to main content
Clinical Trials/NCT01682239
NCT01682239
Unknown
N/A

Effects of Different Right Ventricular Lead Positioning on Cardiac Contraction Measured by Cardiac MRI: a Pilot Trial

Medical University of Vienna1 site in 1 country24 target enrollmentSeptember 2012

Overview

Phase
N/A
Intervention
Not specified
Conditions
Late Complication From Cardiac Pacemaker Implantation
Sponsor
Medical University of Vienna
Enrollment
24
Locations
1
Primary Endpoint
Ejection Fraction
Last Updated
13 years ago

Overview

Brief Summary

Chronic right ventricular apical pacing has been associated with negative hemodynamic effects. Clinical outcome of right ventricular pacing can be influenced by multiple factors. An important factor seems to be optimal lead positioning. Data regarding left ventricular function impaired by lead positioning is insufficient. The aim of the present study therefore is to compare right ventricular apical pacing (RVAP) with right ventricular septal pacing (RVSP). Outcome measurements are echocardiographic features, magnetic resonance imaging and clinical outcome.

Registry
clinicaltrials.gov
Start Date
September 2012
End Date
August 2015
Last Updated
13 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Alfred A Kocher, MD

MD., Prof.

Medical University of Vienna

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Ejection Fraction

Time Frame: 6 month

As primary endpoint the difference of ventricular function in both groups will be taken. Therefore the Ejection Fraction is measured in cardiac MRI and Echocardiography. There may be a different development of contraction, whether the lead is placed in the ventricular apex or the ventricular septum.

Study Sites (1)

Loading locations...

Similar Trials